Two growing trends in pharmaceuticals prompted the development of a new high-performance pouch that addresses the mechanical and purity challenges of packaging a liquid biologic or vaccine that requires low temperatures. The first is the growing trend of biologic drugs, which by nature require cold-chain handling to maintain stability and efficacy. The second reason is the market trend to centralized production of active ingredients, which often means shipping them in bulk to a separate location for manufacturing the final drug.
The Gore Sta-Pure Flexible Freeze Container maintains package integrity after freezing at ‑86 deg C. (‑123 deg F) and minimizes product loss due to package failure due to its durable design. In this Q&A, Joe Cintavey, product manager and specialist for the flexible freeze containers, explains more about how the Gore Sta-Pure Flexible Freeze Container addresses these challenges.
Originally published in Packaging Digest.